Transgenic mice that developed robust neuronal tauopathy were primarily based on transgenic overexpression of mutations that cause FTD with Parkinsonism linked to chromosome 17 (FTD-MAPT) [75,76,77]. The gene discussed is MAPT; the disease is Parkinsonism.